Navigation Links
United BioSource Expands Regulatory Affairs Capabilities
Date:2/25/2008

Former Pfizer executives to lead regulatory affairs group based in Ann

Arbor, Michigan

BETHESDA, Md., Feb. 25 /PRNewswire/ -- United BioSource Corporation (UBC) today announced the expansion of its Regulatory Affairs group led by distinguished experts Mark Ammann, Pharm.D. and LaVonne Lang, Dr PH. Based in Ann Arbor, Michigan, the group will provide a full range of services to pharmaceutical and biotechnology clients, including creating and implementing development plans to fulfill regulatory requirements for initial approval of new medicines and providing life-cycle management for marketed products.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070910/NEM007LOGO )

The Regulatory Affairs group will be headed by Dr. Mark Ammann, a 17-year veteran of the pharmaceutical industry, who has worked with products from early development to post-marketing product support in such diverse therapeutic areas as CNS, oncology, dermatology, inflammation, endocrinology and cardiovascular disorders. Dr. Ammann most recently held the position of Global Head of Regulatory Affairs at Pfizer Corporation where he was responsible for several therapeutic areas including central nervous system, inflammation and dermatology.

"We are thrilled to welcome Dr. Ammann and Dr. Lang to the UBC team. They give us world-class experience and expertise in navigating through the drug development process with the FDA. This capability complements our specialized regulatory knowledge in areas like health outcomes and post-approval research to provide clients unique regulatory insight in both the pre- and post- approval environment," according to Ethan Leder, UBC CEO and Founder.

"Having led many interactions with the FDA over the past 16 years, I am particularly excited about helping clients navigate through the maze of evolving regulations, offering the
'/>"/>

SOURCE United BioSource Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. United Therapeutics Reports Fourth Quarter and Annual 2007 Financial Results
2. United States Patent Office Grants CryoCors Request for Patent Interference
3. United Therapeutics to Announce Fourth Quarter and Annual 2007 Financial Results Before Market Open on Tuesday, February 19, 2008
4. Energy Conversion Devices and United Solar Ovonic Enter Into New $55 Million Secured Credit Facility Agreements
5. Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor
6. Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement
7. Neptune Technologies receives GRAS notification in the United States
8. Essilor: New Acquisitions in the United States and Brazil
9. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
10. Medical Services Begins Working With United States Companies for Distribution of Its Products
11. United Therapeutics Reports Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... Knowledgent , the data and analytics ... advanced analytics utilizing data lakes in the healthcare industry. , As the Internet of ... of data over the last few years as more entities become technology enabled through ...
(Date:9/1/2015)... ... 2015 , ... Industry leader iLab Solutions recently announced Gerard ... position, Gibbs will lead iLab’s business operations in the region, with an emphasis ... not only introducing iLab to potential partners but support and management of accounts ...
(Date:9/1/2015)... CA (PRWEB) , ... September 01, 2015 , ... ... and colleagues from University of California Los Angeles, Boston University School of Medicine, ... Prevention appears in PLOS One, the world’s first multidisciplinary Open Access journal. ...
(Date:9/1/2015)... Shire plc (LSE: SHP, NASDAQ: SHPG ) announces ... of Directors as a Non-Executive Director. Sara will also be ... the Shire Board. Both appointments will be effective as of ... President and Chief Executive Officer of Dun & Bradstreet, Inc. ... D&B, she helped drive the transformation of the company from ...
Breaking Biology Technology:New White Paper Explores Data Lake Opportunities in the Healthcare Industry 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 3Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 3Shire Appoints Sara Mathew to Board of Directors 2
... Mich., Nov. 20 GeneGo, Inc., the ... systems biology, announced,today that Utrecht University will ... for drug innovation. MetaDrug is designed for ... off-target effects for,new compounds structures. Its content ...
... TORONTO, Nov. 20 /PRNewswire-FirstCall/ - ARIUS Research ... developing the next wave of,antibody therapeutics, today ... of Research, will present at the 14th ... Pereira will present on,ARIUS, non-traditional approach to ...
... Beckman Coulter,Inc. (NYSE: BEC ), a ... automate, and innovate complex biomedical testing,announced today that ... present at the Lazard Capital Markets Fourth Annual,Healthcare ... p.m. (ET). (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) ...
Cached Biology Technology:Utrecht University Licenses MetaDrug From GeneGo for Drug Innovation 2ARIUS to present at BioNorth Biotechnology and Life Sciences Conference 2Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 2
(Date:8/6/2015)... and TELTOW, Germany , August ... Siggraph Conference, SensoMotoric Instruments (SMI) shows the ... , based on Epson,s Moverio BT-200 see-through ... platform. With this new solution, unprecedented quality and efficiency ... interaction with context-sensitive displays. For the first time, professionals ...
(Date:8/5/2015)... According to a new market research report, ... (BFSI, Airport, IT & Telecom, Utilities, Education, Defense & ... published by MarketsandMarkets, defines and segments the Physical Identity ... global PIAM Market is estimated to grow from $272.2 ... a CAGR of 14.9 % from 2014 to 2019. ...
(Date:8/5/2015)... MOUNTAIN VIEW, Calif. , Aug. 5, 2015 /PRNewswire/ ... it exhibits continuous growth in applications, penetration into newer ... year after year. The global biosensors space has seen ... having exited the market so far. (Photo ... from Frost & Sullivan, Analysis of the Global ...
Breaking Biology News(10 mins):SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
... microtubules might be responsible for some cases of the neurological ... June 15, 2009 issue of the Journal of Cell ... microtubules too stable to perform their jobs, the researchers find. ... their strength, or both. One of these mutations leads to ...
... and New Zealand researchers have accelerated research into Multiple ... will help to unravel the causes of MS and ... be published today in the prestigious journal Nature ... has remained a mystery. This discovery reveals important new ...
... soil microbe that uses chemical warfare to fight off ... of its arsenal, researchers report, making use of an ... known to do: break a non-activated carbon-carbon bond in ... in the journal Nature , provides the first ...
Cached Biology News:Aussie and Kiwi researchers make double MS genetic discovery 2Researchers describe 'implausible' chemistry that produces herbicidal compound 2
... sets a new standard for high performance ... new design in instrumentation, this easy-to-use benchtop ... The BD FACSAria instrument is the first ... flow cell. This new flow cell ...
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Mouse polyclonal antibody raised against a partial recombinant IFNA13. NCBI Entrez Gene ID = 3447...
Mouse monoclonal antibody raised against a full length recombinant LDB3. NCBI Entrez Gene ID = LDB3...
Biology Products: